Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

NCT05062655 is registered in ClinicalTrials.gov with Centre Hospitalier le Mans as lead sponsor.

NCT NCT05062655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05062655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge
Lead sponsor
Centre Hospitalier le Mans
Phase
Not applicable
Overall status
Completed
Start date
November 8, 2021
Completion date
November 12, 2022
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospitalized patient